Propanc Pancreatic Treatment Meets FDA Milestone
Cancer patients with pancreatic, ovarian, or colorectal tumors have reason for hope. A solid tumor treatment known as PRP, developed by Propanc Biopharma Inc. (PPCB), has received an Orphan Drug Designation from the U.S. Food & Drug Administration as the company prepares to move forward into first-in-human studies. PRP is an intravenous solution designed for […]